X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - NLM.NIH.GOV - DailyMed Drug Label Updates - 10/Jan 05:00

MESALAMINE suppository [Zydus Pharmaceuticals USA Inc.]

Updated Date: Fri, 10 Jan 2025 00:00:00 EST

Articles similaires

Sorry! Image not available at this time

MESALAMINE suppository [Zydus Lifesciences Limited]

nlm.nih.gov - 10/Jan 05:00

Updated Date: Fri, 10 Jan 2025 00:00:00 EST

Sorry! Image not available at this time

AZITHROMYCIN powder, for suspension [Zydus Pharmaceuticals USA Inc.]

nlm.nih.gov - 10/Jan 05:00

Updated Date: Fri, 10 Jan 2025 00:00:00 EST

Sorry! Image not available at this time

AZITHROMYCIN powder, for suspension [Zydus Pharmaceuticals USA Inc.]

nlm.nih.gov - 10/Jan 05:00

Updated Date: Fri, 10 Jan 2025 00:00:00 EST

Sorry! Image not available at this time

EXEMESTANE tablet [Zydus Pharmaceuticals USA Inc.]

nlm.nih.gov - 03/Jan 05:00

Updated Date: Fri, 03 Jan 2025 00:00:00 EST

Sorry! Image not available at this time

TERIFLUNOMIDE tablet, film coated [Zydus Pharmaceuticals USA Inc.]

nlm.nih.gov - 03/Jan 05:00

Updated Date: Fri, 03 Jan 2025 00:00:00 EST

Sorry! Image not available at this time

DOXYCYCLINE injection, powder, lyophilized, for solution [Zydus Pharmaceuticals USA Inc.]

nlm.nih.gov - 02/Jan 05:00

Updated Date: Thu, 02 Jan 2025 00:00:00 EST

Sorry! Image not available at this time

ANASTROZOLE tablet, coated [Zydus Pharmaceuticals USA Inc.]

nlm.nih.gov - 08/Jan 05:00

Updated Date: Wed, 08 Jan 2025 00:00:00 EST

Sorry! Image not available at this time

EXEMESTANE tablet, film coated [Hikma Pharmaceuticals USA Inc]

nlm.nih.gov - 10/Jan 05:00

Updated Date: Fri, 10 Jan 2025 00:00:00 EST

Sorry! Image not available at this time

EXEMESTANE tablet, film coated [Hikma Pharmaceuticals USA Inc]

nlm.nih.gov - 10/Jan 05:00

Updated Date: Fri, 10 Jan 2025 00:00:00 EST

Sorry! Image not available at this time

AMOXICILLIN AND CLAVULANATE POTASSIUM tablet [Hikma Pharmaceuticals USA Inc.]

nlm.nih.gov - 10/Jan 05:00

Updated Date: Fri, 10 Jan 2025 00:00:00 EST

Les derniers communiqués